The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review - PubMed (original) (raw)
Review
. 2011 Aug 30;415(1-2):34-52.
doi: 10.1016/j.ijpharm.2011.05.049. Epub 2011 May 27.
Affiliations
- PMID: 21640806
- DOI: 10.1016/j.ijpharm.2011.05.049
Review
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review
Susanne Fredenberg et al. Int J Pharm. 2011.
Abstract
Poly(D,L-lactic-co-glycolic acid) (PLGA) is the most frequently used biodegradable polymer in the controlled release of encapsulated drugs. Understanding the release mechanisms, as well as which factors that affect drug release, is important in order to be able to modify drug release. Drug release from PLGA-based drug delivery systems is however complex. This review focuses on release mechanisms, and provides a survey and analysis of the processes determining the release rate, which may be helpful in elucidating this complex picture. The term release mechanism and the various techniques that have been used to study release mechanisms are discussed. The physico-chemical processes that influence the rate of drug release and the various mechanisms of drug release that have been reported in the literature are analyzed in this review, and practical examples are given. The complexity of drug release from PLGA-based drug delivery systems can make the generalization of results and predictions of drug release difficult. However, this complexity also provides many possible ways of solving problems and modifying drug release. Basic, generally applicable and mechanistic research provides pieces of the puzzle, which is useful in the development of controlled-release pharmaceuticals.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
- Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
Hines DJ, Kaplan DL. Hines DJ, et al. Crit Rev Ther Drug Carrier Syst. 2013;30(3):257-76. doi: 10.1615/critrevtherdrugcarriersyst.2013006475. Crit Rev Ther Drug Carrier Syst. 2013. PMID: 23614648 Free PMC article. - PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D, Siepmann F, Elkharraz K, Siepmann J. Klose D, et al. Int J Pharm. 2008 Apr 16;354(1-2):95-103. doi: 10.1016/j.ijpharm.2007.10.030. Epub 2007 Oct 30. Int J Pharm. 2008. PMID: 18055140 - High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM. Cun D, et al. Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18. Eur J Pharm Biopharm. 2011. PMID: 21093589 - Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms.
Houchin ML, Topp EM. Houchin ML, et al. J Pharm Sci. 2008 Jul;97(7):2395-404. doi: 10.1002/jps.21176. J Pharm Sci. 2008. PMID: 17828756 Review. - Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Mundargi RC, et al. J Control Release. 2008 Feb 11;125(3):193-209. doi: 10.1016/j.jconrel.2007.09.013. Epub 2007 Oct 22. J Control Release. 2008. PMID: 18083265 Review.
Cited by
- Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3-dioxygenase inhibitor immunotherapeutic.
Badiee P, Maritz MF, Dehghankelishadi P, Dmochowska N, Thierry B. Badiee P, et al. Bioeng Transl Med. 2023 Oct 28;9(1):e10599. doi: 10.1002/btm2.10599. eCollection 2024 Jan. Bioeng Transl Med. 2023. PMID: 38193128 Free PMC article. - Polyactives: controlled and sustained bioactive release via hydrolytic degradation.
Stebbins ND, Faig JJ, Yu W, Guliyev R, Uhrich KE. Stebbins ND, et al. Biomater Sci. 2015 Aug;3(8):1171-87. doi: 10.1039/c5bm00051c. Epub 2015 Jun 2. Biomater Sci. 2015. PMID: 26222033 Free PMC article. - Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model.
Chitkara D, Nikalaje SK, Mittal A, Chand M, Kumar N. Chitkara D, et al. Drug Deliv Transl Res. 2012 Apr;2(2):112-23. doi: 10.1007/s13346-012-0063-5. Drug Deliv Transl Res. 2012. PMID: 25786720 - Additive Manufacturing of Drug-Eluting Multilayer Biodegradable Films.
Proshin PI, Abdurashitov AS, Sindeeva OA, Ivanova AA, Sukhorukov GB. Proshin PI, et al. Polymers (Basel). 2022 Oct 14;14(20):4318. doi: 10.3390/polym14204318. Polymers (Basel). 2022. PMID: 36297899 Free PMC article. - Intracochlear PLGA based implants for dexamethasone release: Challenges and solutions.
Lehner E, Gündel D, Liebau A, Plontke S, Mäder K. Lehner E, et al. Int J Pharm X. 2019 May 21;1:100015. doi: 10.1016/j.ijpx.2019.100015. eCollection 2019 Dec. Int J Pharm X. 2019. PMID: 31517280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources